GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (LTS:0M2O) » Definitions » Other Long-Term Liabilities

Orion Oyj (LTS:0M2O) Other Long-Term Liabilities : €108 Mil (As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Orion Oyj Other Long-Term Liabilities?

Orion Oyj's other long-term liabilities for the quarter that ended in Jun. 2024 was €108 Mil.

Orion Oyj's quarterly other long-term liabilities increased from Dec. 2023 (€109 Mil) to Mar. 2024 (€109 Mil) but then declined from Mar. 2024 (€109 Mil) to Jun. 2024 (€108 Mil).

Orion Oyj's annual other long-term liabilities increased from Dec. 2021 (€47 Mil) to Dec. 2022 (€120 Mil) but then declined from Dec. 2022 (€120 Mil) to Dec. 2023 (€109 Mil).

Orion Oyj Other Long-Term Liabilities Historical Data

The historical data trend for Orion Oyj's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj Other Long-Term Liabilities Chart

Orion Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Orion Oyj Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Orion Oyj Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Orion Oyj Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Orion Oyj's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Oyj Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (LTS:0M2O) » Definitions » Other Long-Term Liabilities
Comparable Companies
OSTO:SWED A OSTO:NORION OSTO:SEB A OSTO:TFBANK OSTO:AZA LLY JNJ ABBV MRK XSWX:ROG LSE:AZN XSWX:NOVN AMGN PFE XPAR:SAN GILD BMY TSE:4519 LSE:GSK TSE:4568
Traded in Other Exchanges
ORINY:USA 1ORNBV:Italy ORNBVh:UK 0M2N:UK ORNBV:Finland ORNAV:Finland OFK:Germany
Address
Orionintie 1, Espoo, FIN, FI-02200
Website
https://www.orion.fi
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.

Orion Oyj Headlines

No Headlines